C4A and hereditary angioedema: Following our experience with DBS based assays we decided to develop an in‐house multiple reaction monitoring (MRM) mass spectrometric assay for the quantification of C1‐INH/C4 proteins that can be used for screening HAE patients in a high throughput environment.